Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon Lambda-1a in Hospitalized COVID-19
NCT04388709Phase 2Withdrawn
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Sep 2020
- Primary completion
- Feb 2021
- Modality
- Cytokines & Interferons
01
Overview
A Phase 2 trial of peginterferon lambda-1a in coronavirus disease 2019 (COVID-19), sponsored by Icahn School of Medicine at Mount Sinai. Planned start Sep 2020; status: withdrawn.
02
Drugs
peginterferon lambda-1a
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04388709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04388709.